SCHEMBL8036084

SCHEMBL8036084

CCN1/C(=C/C(=O)Nc2ccccc2)Sc2ccc(OC)cc21

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.69
DYRK1A Q13627 6/20 0.69
ALDH1A1 P00352 5/20 0.69
HSD17B10 Q99714 4/20 0.69
CLK1 P49759 4/20 0.69
CSNK1E P49674 3/20 0.69
CLK3 P49761 3/20 0.69
DYRK1B Q9Y463 3/20 0.69
HPGD P15428 3/20 0.69
HTT P42858 3/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
PIM1 P11309 2/20 0.69
CSNK1D P48730 2/20 0.69
CSNK1G2 P78368 2/20 0.69
MAP3K19 Q56UN5 2/20 0.69
PIM3 Q86V86 2/20 0.69
CSNK1G3 Q9Y6M4 2/20 0.69
NPSR1 Q6W5P4 2/20 0.69
SMN1; SMN2 Q16637 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020524 0.93 DYRK1A (0.67) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL8030185 0.89 HSD17B10 (0.64) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL8034733 0.86 MAPT (0.54) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL8036087 0.84 DYRK1A (0.74) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL8029739 0.83 DYRK1A (0.57) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL2977826 0.82 DYRK1A (1.00) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL2977830 0.82 DYRK1A (1.00) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL24718937 0.81 MAPT (1.00) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL8031777 0.79 DYRK1A (0.76) MAPTDYRK1AALDH1A1HSD17B10CLK1
SCHEMBL4157023 0.79 DYRK1A (0.76) MAPTDYRK1AALDH1A1HSD17B10CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed